Syndax Pharmaceuticals
SNDX
SNDX
66 hedge funds and large institutions have $219M invested in Syndax Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 63 → 66 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.3M | |
| 2 | +$7.5M | |
| 3 | +$6.48M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.08M |
| 5 |
BlackRock
New York
|
+$5.86M |
Top Sellers
| 1 | -$3.3M | |
| 2 | -$1.36M | |
| 3 | -$824K | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$686K |
| 5 |
O
OrbiMed
New York
|
-$668K |